The Beaumont behavioral intervention in a Chinese amyotrophic lateral sclerosis cohort

Reference

• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Bersano E, Sarnelli MF, Solara V, Iazzolino B, Peotta L, De Marchi F, et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:373–9.
   PubMed Web of Science ®Google Scholar
• Mehl T, Jordan B, Zierz S. “Patients with amyotrophic lateral sclerosis (ALS) are usually nice persons”-How physicians experienced in ALS see the personality characteristics of their patients. Brain Behav. 2017;7:e00599.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Mariosa D, Larsson H, Ye W, Ingre C, Almqvist C, et al. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis. Neurology 2017;89:578–85.
   PubMed Web of Science ®Google Scholar
• Turner MR, Goldacre R, Talbot K, Goldacre MJ. Psychiatric disorders prior to amyotrophic lateral sclerosis. Ann Neurol. 2016;80:935–8.
   PubMed Web of Science ®Google Scholar
• Mioshi E, Caga J, Lillo P, Hsieh S, Ramsey E, Devenney E, et al. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology 2014;82:149–55.
   PubMed Web of Science ®Google Scholar
• Nguyen C, Caga J, Mahoney CJ, Kiernan MC, Huynh W. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn. 2021;150:105710.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, et al. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305–17.
   PubMed Web of Science ®Google Scholar
• Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh cognitive and behavioural ALS Screen in a Chinese amyotrophic lateral sclerosis population. PLOS One. 2016;11:e0155496.
   PubMed Web of Science ®Google Scholar
• Chio A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 2019;93:e984–e994.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Burgunder JM. Recent progress in the genetics of motor neuron disease. Eur J Med Genet. 2014;57:103–12.
   PubMed Web of Science ®Google Scholar
• Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, et al. Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China. J Neurol. 2014;261:2393–400.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, Schmand B, Berkhout J, Linssen WH, van den Berg LH, et al. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS. Neurology 2012;79:1377–83.
   PubMed Web of Science ®Google Scholar
• Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, et al. Identifying behavioural changes in ALS: validation of the Beaumont behavioural inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:68–73.
   PubMed Web of Science ®Google Scholar
• Iazzolino B, Pain D, Laura P, Aiello EN, Gallucci M, Radici A, et al. Italian adaptation of the Beaumont behavioral inventory (BBI): psychometric properties and clinical usability. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:81–6.
   PubMed Web of Science ®Google Scholar
• Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480–93.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.
   PubMed Web of Science ®Google Scholar
• Shi Y, Liao Y, Zhou Y, Liu H, Lei Y, Luo L. Anxiety, depression, and related factors in hemodialysis patients during the lockdown period of COVID- 19 in China: a multicenter study. Psychol Health Med. 2023;28:1513–19.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Namazov A, Kathurusinghe S, Mehdi E, Merlot B, Prosszer M, Tuech JJ, et al. Evolution of bowel complaints after Laparoscopic endometriosis surgery: a 1497 women comparative study. J Minim Invasive Gynecol. 2022;29:499–506.
   PubMed Web of Science ®Google Scholar
• Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47:458–72.
   PubMed Web of Science ®Google Scholar
• Li HF, Wu ZY. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener. 2016;5:3.
   PubMed Web of Science ®Google Scholar
• Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, Montuschi A. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci. 2011;32:9–16.
   PubMed Web of Science ®Google Scholar
• van der Ende EL, Jackson JL, White A, Seelaar H, van Blitterswijk M, Van Swieten JC. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions. J Neurol Neurosurg Psychiatry. 2021;92:502–9.
   PubMed Web of Science ®Google Scholar
• Roggenbuck J, Quick A, Kolb SJ. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2017;19:267–74.
   PubMed Web of Science ®Google Scholar
• Gossink F, Dols A, Stek ML, Scheltens P, Nijmeijer B, Cohn Hokke P, et al. Early life involvement in C9orf72 repeat expansion carriers. J Neurol Neurosurg Psychiatry. 2022;93:93–100.
   PubMed Web of Science ®Google Scholar
• Zucchi E, Ticozzi N, Mandrioli J. Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci. 2019;13:175.
   PubMed Web of Science ®Google Scholar
• Piccione EA, Sletten DM, Staff NP, Low PA. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676–9.
   PubMed Web of Science ®Google Scholar
• Fang T, Jozsa F, Al-Chalabi A. Nonmotor symptoms in amyotrophic lateral sclerosis: a systematic review. Int Rev Neurobiol. 2017;134:1409–41.
   PubMed Web of Science ®Google Scholar
• Chio A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life. Eur J Neurol. 2010;17:1298–303.
   PubMed Web of Science ®Google Scholar